Search clinical trials for: RO7303509

Total 2 results

Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

Systemic Sclerosis

Belgium, United States, Spain, France, Portugal, Germany, United Kingdom, Israel, Poland, Argentina, Puerto Rico, Serbia
Hoffmann-La Roche

Completed

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy

United States

3

Subscribe